Avita (RCEL) 2026 Earnings: Outlook & Insights for Investors
As investors scan the horizon for regenerative medicine players, Avita (RCEL) faces a pivotal quarter. This guide bre...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
158 articlesCelcuity (CELC) 2026 Earnings: What Investors Need
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
Capricor (CAPR) 2026 Earnings Outlook: Roadmap
Capricor is at a crossroads as 2026 earnings season unfolds. This article breaks down what to look for in capricor (c...
Senestech SNES 2026 Earnings: Q1 Outlook for Investors
This deep-dive breaks down senestech snes 2026 earnings for Q1, translating the numbers into practical signals for in...
Invivyd (IVVD) 2026 Earnings: Outlook and Key Trends
As the first quarter of 2026 unfolds, invivyd ivvd 2026 earnings take center stage for investors watching the biotech...
MdxHealth (MDXH) 2026 Earnings: A Clear Investor's Guide
Investors eyeing mdxhealth (mdxh) 2026 earnings will focus on adoption rates, reimbursement, and partnerships. This g...
Milestone Pharmaceuticals Stock Wilted: Midweek Decline
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
Veru (Veru) 2026 Earnings: What to Watch Now
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
Exagen (XGN) 2026 Earnings Outlook and Q1 Review
This article dives into exagen (XGN) 2026 earnings, unpacking Q1 results, business momentum, and the path to full-yea...
Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Moderna Stock Today: Outperforming Peers in 2026 Rally
Moderna shares rose about 6% early trading after better-than-expected Q1 results and renewed vaccine interest. Pfizer...
This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Related Topics
#Investing (126)
#Stock Analysis (39)
#Earnings Analysis (28)
#Insider Trading (22)
#Stock Market (16)
#Stock Market News (16)
#Earnings (14)
#Portfolio Strategy (12)
#Portfolio Management (11)
#Investing Strategy (9)
#SEC Filings (7)
#risk-management (6)
#Hedge Funds (6)
#CRISPR (6)
#Pharmaceuticals (5)